Comparative Effects of Efavirenz and Dolutegravir on Metabolomic and Inflammatory Profiles, and Platelet Activation of People Living with HIV: A Pilot Study
Viruses · 14.09.2024 · 16 (9) · 1462
DOI: 10.3390/v16091462 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Viruses, online erschienen am 14.09.2024. Verfasst von Crystal G Roux und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria 0001, South Africa. Hauptthemen laut MEDLINE: HIV Infections, Cyclopropanes, Alkynes, Platelet Activation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health Laboratory Service, National Health Laboratory Service Trust Fund, University of Pretoria School of Medicine Research Committee.
Abstract (Originalsprache)
Antiretroviral therapy (ART) has reduced the mortality and morbidity associated with HIV. However, irrespective of treatment, people living with HIV remain at a higher risk of developing non-AIDS-associated diseases. In 2019, the World Health Organization recommended the transition from efavirenz (EFV)- to dolutegravir (DTG)-based ART. Data on the impact of this transition are still limited. The current study therefore investigated the metabolic profiles, cytokine inflammatory responses, and platelet activation before and after the treatment transition. Plasma samples from nine virally suppressed adults living with HIV and sixteen healthy, HIV-uninfected individuals residing in Gauteng, South Africa were compared. Metabolite and cytokine profiles, and markers associated with platelet activation, were investigated with untargeted proton magnetic resonance metabolomics, multiplex suspension bead array immunoassays, and sandwich enzyme-linked immunosorbent assays, respectively. In those individuals with normal C-reactive protein levels, the transition to a DTG-based ART regimen resulted in decreased concentrations of acetoacetic acid, creatinine, adenosine monophosphate, 1,7-dimethylxanthine, glycolic acid, 3-hydroxybutyric acid, urea, and lysine. Moreover, increased levels of formic acid, glucose, lactic acid, myo-inositol, valine, glycolic acid, and 3-hydroxybutyric acid were observed. Notably, levels of interleukin-6, platelet-derived growth factor-BB, granulocyte-macrophage colony-stimulating factor, tumor necrosis factor–alpha, soluble cluster of differentiation 40 ligand, as well as regulated on activation, normal T-cell expressed and secreted (RANTES) reached levels close to those observed in the healthy control participants. The elevated concentration of macrophage inflammatory protein-1 alpha was the only marker indicative of elevated levels of inflammation associated with DTG-based treatment. The transition from EFV- to DTG-based regimens therefore appears to be of potential benefit with metabolic and inflammatory markers, as well as those associated with cardiovascular disease and other chronic non-AIDS-related diseases, reaching levels similar to those observed in individuals not living with HIV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria 0001, South Africa.
- Human Metabolomics, Faculty of Natural and Agricultural Sciences, North-West University, Potchefstroom 2520, South Africa.
- Department of Haematology, Faculty of Health Sciences, University of Pretoria, Pretoria 0001, South Africa.
ORCID-Profile: Crystal G Roux, Shayne Mason, Louise D V du Toit, Jan-Gert Nel, Theresa M Rossouw, Helen C Steel
Förderung
- National Health Laboratory Service
- National Health Laboratory Service Trust Fund
- University of Pretoria School of Medicine Research Committee
Zitieren
APA
Roux, C. G., Mason, S., du Toit, L. D. V., Nel, J. G., Rossouw, T. M., & Steel, H. C. (2024). Comparative Effects of Efavirenz and Dolutegravir on Metabolomic and Inflammatory Profiles, and Platelet Activation of People Living with HIV: A Pilot Study. Viruses, 16(9), 1462. https://doi.org/10.3390/v16091462
Vancouver
Roux CG, Mason S, du Toit LDV, Nel JG, Rossouw TM, Steel HC. Comparative Effects of Efavirenz and Dolutegravir on Metabolomic and Inflammatory Profiles, and Platelet Activation of People Living with HIV: A Pilot Study. Viruses. 2024;16(9):1462. doi:10.3390/v16091462
BibTeX
@article{Roux2024,
author = {Roux, Crystal G and Mason, Shayne and du Toit, Louise D V and Nel, Jan-Gert and Rossouw, Theresa M and Steel, Helen C},
title = {Comparative Effects of Efavirenz and Dolutegravir on Metabolomic and Inflammatory Profiles, and Platelet Activation of People Living with HIV: A Pilot Study},
journal = {Viruses},
year = {2024},
volume = {16},
number = {9},
pages = {1462},
doi = {10.3390/v16091462}
}
EUVIMED